179 related articles for article (PubMed ID: 9004052)
1. Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder.
Baker B; Dorian P; Sandor P; Shapiro C; Schell C; Mitchell J; Irvine MJ
J Clin Psychopharmacol; 1997 Feb; 17(1):15-21. PubMed ID: 9004052
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
[TBL] [Abstract][Full Text] [Related]
3. Autonomic correlates of antidepressant treatment using heart-rate variability analysis.
Khaykin Y; Dorian P; Baker B; Shapiro C; Sandor P; Mironov D; Irvine J; Newman D
Can J Psychiatry; 1998 Mar; 43(2):183-6. PubMed ID: 9533973
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparative trials of fluoxetine and doxepin in geriatric patients with major depressive disorder.
Feighner JP; Cohn JB
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):20-5. PubMed ID: 3882676
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine vs. tricyclic antidepressants in women with major depressive disorder.
Lewis-Hall FC; Wilson MG; Tepner RG; Koke SC
J Womens Health; 1997 Jun; 6(3):337-43. PubMed ID: 9201668
[TBL] [Abstract][Full Text] [Related]
6. Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression.
Akhondzadeh S; Faraji H; Sadeghi M; Afkham K; Fakhrzadeh H; Kamalipour A
J Clin Pharm Ther; 2003 Oct; 28(5):379-84. PubMed ID: 14632962
[TBL] [Abstract][Full Text] [Related]
7. A double-blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders.
Tamminen TT; Lehtinen VV
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():51-6. PubMed ID: 2783699
[No Abstract] [Full Text] [Related]
8. Prolonged QT interval in an infant of a fluoxetine treated mother.
Dubnov G; Fogelman R; Merlob P
Arch Dis Child; 2005 Sep; 90(9):972-3. PubMed ID: 16113135
[TBL] [Abstract][Full Text] [Related]
9. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group.
Clerc GE; Ruimy P; Verdeau-Pallès J
Int Clin Psychopharmacol; 1994 Sep; 9(3):139-43. PubMed ID: 7814822
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
Winokur A; DeMartinis NA; McNally DP; Gary EM; Cormier JL; Gary KA
J Clin Psychiatry; 2003 Oct; 64(10):1224-9. PubMed ID: 14658972
[TBL] [Abstract][Full Text] [Related]
11. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
[TBL] [Abstract][Full Text] [Related]
12. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
[TBL] [Abstract][Full Text] [Related]
13. Predictors of response to amine-specific antidepressants.
Burns RA; Lock T; Edwards DR; Katona CL; Harrison DA; Robertson MM; Nairac B; Abou-Saleh MT
J Affect Disord; 1995 Dec; 35(3):97-106. PubMed ID: 8749837
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
[TBL] [Abstract][Full Text] [Related]
15. A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression.
Marttila M; Jääskeläinen J; Järvi R; Romanov M; Miettinen E; Sorri P; Ahlfors U; Zivkov M
Eur Neuropsychopharmacol; 1995 Dec; 5(4):441-6. PubMed ID: 8998395
[TBL] [Abstract][Full Text] [Related]
16. A double-blind comparison of moclobemide and doxepin in depressed general practice patients.
Lingjaerde O; Jørgensen J; Støren R; Thomle S; Wendt Raeder L; Ruud LE; Schetelig E; Sveaas HK; Leivestad O
Acta Psychiatr Scand; 1995 Aug; 92(2):125-31. PubMed ID: 7572258
[TBL] [Abstract][Full Text] [Related]
17. A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation.
Mansbach RS; Ludington E; Rogowski R; Kittrelle JP; Jochelson P
Clin Ther; 2011 Jul; 33(7):851-62. PubMed ID: 21722958
[TBL] [Abstract][Full Text] [Related]
18. Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group.
Demyttenaere K; Van Ganse E; Gregoire J; Gaens E; Mesters P
Int Clin Psychopharmacol; 1998 Jan; 13(1):11-7. PubMed ID: 9988362
[TBL] [Abstract][Full Text] [Related]
19. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
[TBL] [Abstract][Full Text] [Related]
20. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
Marchesi C; Ceccherininelli A; Rossi A; Maggini C
Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
